These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant. Bouillet L, Boccon-Gibod I, Launay D, Gompel A, Kanny G, Fabien V, Fain O, IOS Study Group. Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922 [Abstract] [Full Text] [Related]
3. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency. Zanichelli A, Azin GM, Wu MA, Suffritti C, Maggioni L, Caccia S, Perego F, Vacchini R, Cicardi M. J Allergy Clin Immunol Pract; 2017 Mar; 5(5):1307-1313. PubMed ID: 28284781 [Abstract] [Full Text] [Related]
5. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries. Toubi E, Kivity S, Graif Y, Reshef A, Botha J, Andresen I. Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730 [Abstract] [Full Text] [Related]
6. Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study. Grumach AS, Henriques MT, Bardou MLD, Pontarolli DA, Botha J, Correa M, IOS Brazil Study Group. An Bras Dermatol; 2022 Apr; 97(4):448-457. PubMed ID: 35654647 [Abstract] [Full Text] [Related]
9. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R, Stieber C, Cichon S, Cicardi M. J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353 [Abstract] [Full Text] [Related]
10. A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data. Johnson F, Stenzl A, Hofauer B, Heppt H, Ebert EV, Wollenberg B, Lochbaum R, Hahn J, Greve J, Trainotti S. Clin Rev Allergy Immunol; 2023 Dec; 65(3):354-364. PubMed ID: 37914894 [Abstract] [Full Text] [Related]
11. Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)-A Bicenter Retrospective Study on Diagnosis, Course, and Therapy. Trainotti S, Johnson F, Hahn J, Hofauer B, Greve J, Wollenberg B, Hoffmann TK, Lochbaum R. J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3772-3779. PubMed ID: 37716525 [Abstract] [Full Text] [Related]
12. Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting. Maurer M, Longhurst HJ, Fabien V, Li HH, Lumry WR. Allergy Asthma Proc; 2014 Dec; 35(5):377-81. PubMed ID: 25198193 [Abstract] [Full Text] [Related]
14. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients. Federici C, Perego F, Borsoi L, Crosta V, Zanichelli A, Gidaro A, Tarricone R, Cicardi M. BMJ Open; 2018 Jul 30; 8(7):e022291. PubMed ID: 30061443 [Abstract] [Full Text] [Related]
15. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy. Hakl R, Kuklínek P, Krčmová I, Králíčková P, Freiberger T, Janků P, Vlková M, Litzman J. J Clin Immunol; 2018 Oct 30; 38(7):810-815. PubMed ID: 30280305 [Abstract] [Full Text] [Related]
19. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. Zanichelli A, Longhurst HJ, Maurer M, Bouillet L, Aberer W, Fabien V, Andresen I, Caballero T, IOS Study Group. Ann Allergy Asthma Immunol; 2016 Oct 30; 117(4):394-398. PubMed ID: 27742086 [Abstract] [Full Text] [Related]